We are international
Donate
TEXT SIZE   


ASCO 2012: Dr. Plesner - Daratumumab, a CD38 mab, for the treatment of relapsed/refractory multiple myeloma patients: Preliminary efficacy data from a multicenter phase I/II study.
Torben Plesner, MD
Vejle Hospital
Vejle, Denmark
06.26.12


To view the video full screen, click on the small button next to the volume control in the lower right hand corner.


 related articles